Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease (Q38512084)

3 September 2017

1 reference

title

Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease (English)

1 reference

3 September 2017

Kou Takahashi

1

1 reference

PubMed ID

26033496

3 September 2017

Joshua B Foster

series ordinal

2

1 reference

PubMed ID

26033496

3 September 2017

Chien-Liang Glenn Lin

series ordinal

3

1 reference

3 September 2017

2 June 2015

1 reference

Cellular and Molecular Life Sciences

3 September 2017

1 reference

3 September 2017

72

1 reference

3 September 2017

3489-3506

1 reference

3 September 2017

18

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-015-1937-8

3 September 2017

0 references

cites work

Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

SLC1 glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Electrogenic glutamate transporters in the CNS: molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mechanisms of glutamate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Localization of neuronal and glial glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

High-affinity Na+/K+-dependent glutamate transporter EAAT4 is expressed throughout the rat fore- and midbrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The GLT-1 (EAAT2; slc1a2) glutamate transporter is essential for glutamate homeostasis in the neocortex of the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Brain glutamate transporter proteins form homomultimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Cloning and characterization of the 3'-untranslated region of the human excitatory amino acid transporter 2 transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Altered expression of the glutamate transporter EAAT2b in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Functional modulation of the glutamate transporter variant GLT1b by the PDZ domain protein PICK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Complementary neuronal and glial expression of two high-affinity glutamate transporter GLT1/EAAT2 forms in rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Distribution of two splice variants of the glutamate transporter GLT-1 in rat brain and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: implications for CNS glutamate homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

cAMP response element-binding protein (CREB) and nuclear factor κB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The CpG island shore of the GLT-1 gene acts as a methylation-sensitive enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Translational Control of Glial Glutamate Transporter EAAT2 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2-dependent ubiquitination but not phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

PKC-dependent endocytosis of the GLT1 glutamate transporter depends on ubiquitylation of lysines located in a C-terminal cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuronal activity regulates glutamate transporter dynamics in developing astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuronal-induced and glutamate-dependent activation of glial glutamate transporter function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitatory amino acid transporters as potential drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

An excitatory amino-acid transporter with properties of a ligand-gated chloride channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Comparative analysis of sodium-dependent L-glutamate transport of synaptosomal and astroglial membrane vesicles from mouse cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mechanism of inhibition of the glutamate transporter EAAC1 by the conformationally constrained glutamate analogue (+)-HIP-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reupta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Allosteric modulation of an excitatory amino acid transporter: the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

New views of glutamate transporter structure and function: advances and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Transport mechanism of a bacterial homologue of glutamate transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Structure of a glutamate transporter homologue from Pyrococcus horikoshii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A trimeric quaternary structure is conserved in bacterial and human glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Hetero-oligomerization of neuronal glutamate transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Extracellular glutamate concentration in hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporters: confining runaway excitation by shaping synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Kinetics of a human glutamate transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Enhancement of glutamate release uncovers spillover-mediated transmission by N-methyl-D-aspartate receptors in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Relationship between increase in astrocytic GLT-1 glutamate transport and late-LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Extrasynaptic NMDA receptor involvement in central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitotoxicity and stroke: identifying novel targets for neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Cataplerotic TCA cycle flux determined as glutamate-sustained oxygen consumption in primary cultures of astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Organization of NMDA receptors at extrasynaptic locations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The competitive transport inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

EAAT2 (GLT-1; slc1a2) glutamate transporters reconstituted in liposomes argues against heteroexchange being substantially faster than net uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate translocation of the neuronal glutamate transporter EAAC1 occurs within milliseconds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The glutamate transporter subtypes EAAT4 and EAATs 1-3 transport glutamate with dramatically different kinetics and voltage dependence but share a common uptake mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The discovery of slowness: low-capacity transport and slow anion channel gating by the glutamate transporter EAAT5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Energy transfer from astrocytes to axons: the role of CNS glycogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Characterization of transient focal ischemia-induced increases in extracellular glutamate and aspartate in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Gerbil hippocampal extracellular glutamate and neuronal activity after transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Functional changes of the basal ganglia circuitry in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Targeting glutamatergic synapses in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Effects of ceftriaxone on the behavioral and neuronal changes in an MPTP-induced Parkinson's disease rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The effects of the β-lactam antibiotic, ceftriaxone, on forepaw stepping and L-DOPA-induced dyskinesia in a rodent model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Molecular signaling mechanisms underlying epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mechanisms of epileptogenesis and potential treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Astrocytic regulation of glutamate homeostasis in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Extracellular metabolites in the cortex and hippocampus of epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Expression of the glutamate transporters in human temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Astrocyte-neuron interactions: implications for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Functional changes in astroglial cells in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Astrocytes in the epileptic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter, GLT-1, reduces regional gliosis, and reduces post-traumatic seizures in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Hippocampal glutamate transporter 1 (GLT-1) complex levels are paralleling memory training in the Multiple T-maze in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Functional neuroimaging of major depressive disorder: a meta-analysis and new integration of base line activation and neural response data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Low glial numbers in the amygdala in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial and glutamatergic markers in depression, alcoholism, and their comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

An open-label trial of riluzole in patients with treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Region-selective stress-induced increase of glutamate uptake and release in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Acute restraint stress enhances calcium mobilization and glutamate exocytosis in cerebrocortical synaptosomes from mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glucocorticoid regulation of GLT-1 glutamate transporter isoform expression in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Repeated restraint stress alters hippocampal glutamate uptake and release in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Predictable chronic mild stress in adolescence increases resilience in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glia mechanisms in mood regulation: a novel model of mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glial dysfunction in the mouse habenula causes depressive-like behaviors and sleep disturbance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Antidepressant-like effects of ceftriaxone in male C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The glutamate homeostasis hypothesis of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Alcohol-seeking behavior is associated with increased glutamate transmission in basolateral amygdala and nucleus accumbens as measured by glutamate-oxidase-coated biosensors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Reinstatement of nicotine seeking is mediated by glutamatergic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate release in the nucleus accumbens core is necessary for heroin seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

New medications for drug addiction hiding in glutamatergic neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

beta-Lactam antibiotic inhibits development of morphine physical dependence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

SLC1 glutamate transporters and diseases: psychiatric diseases and pathological pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

GLT-1 up-regulation enhances the effect of PCP on prepulse inhibition of the startle reflex in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporters: animal models to neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

High-affinity glutamate transporters in chronic pain: an emerging therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

An anti-nociceptive role for ceftriaxone in chronic neuropathic pain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Glutamate transporters in the biology of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Mapping autism risk loci using genetic linkage and chromosomal rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-015-1937-8

Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

21 January 2018

1 reference

12 December 2020

Isolation of current components and partial reaction cycles in the glial glutamate transporter EAAT2.

1 reference

12 December 2020

Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry

1 reference

12 December 2020

A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder

1 reference

12 December 2020

Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.

1 reference

12 December 2020

An astrocytic basis of epilepsy

1 reference

12 December 2020

Glutamate pays its own way in astrocytes

1 reference

12 December 2020

Transporters buffer synaptically released glutamate on a submillisecond time scale.

1 reference

12 December 2020

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

12 December 2020

Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom

1 reference

12 December 2020

Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism.

1 reference

12 December 2020

Block of glutamate transporters potentiates postsynaptic excitation

1 reference

12 December 2020

Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1.

1 reference

12 December 2020

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

1 reference

12 December 2020

Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain

1 reference

12 December 2020

Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells

1 reference

12 December 2020

Metabolism of [U-13C]glutamate in astrocytes studied by 13C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle

1 reference

12 December 2020

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

1 reference

12 December 2020

EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses.

1 reference

12 December 2020

Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations

1 reference

12 December 2020

Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB

1 reference

12 December 2020

Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.

1 reference

12 December 2020

Glutamate release in severe brain ischaemia is mainly by reversed uptake.

1 reference

12 December 2020

L-TRANs-Pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1, 3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters

1 reference

12 December 2020

Antihyperalgesic/antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents

1 reference

12 December 2020

Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as

1 reference

12 December 2020

Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons

1 reference

12 December 2020

Macroscopic and microscopic properties of a cloned glutamate transporter/chloride channel.

1 reference

12 December 2020

Astrocytic function and its alteration in the epileptic brain

1 reference

12 December 2020

A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain

1 reference

12 December 2020

DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters

1 reference

12 December 2020

Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia.

1 reference

12 December 2020

The glutamate transporter EAAT4 in rat cerebellar Purkinje cells: a glutamate-gated chloride channel concentrated near the synapse in parts of the dendritic membrane facing astroglia.

1 reference

12 December 2020

Anion currents and predicted glutamate flux through a neuronal glutamate transporter.

1 reference

12 December 2020

10.1007/S00018-015-1937-8

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

26033496